Deucravacitinib trials for Plaque Psoriasis

All Deucravacitinib trials · All Plaque Psoriasis trials

Phase breakdown

Recruiting trials studying Deucravacitinib for Plaque Psoriasis

• A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
  NCT06382987 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
  NCT04772079 · Phase: Phase 3 · Ages: 4 Years to 18 Years · Sex: All (male and female) · 65 locations
• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
  NCT06979453 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 132 locations
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · 402 locations

Common questions

How many trials study Deucravacitinib for Plaque Psoriasis?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.